News and events
- All
- Events
- Press releases
- Publications
All
- All
- Events
- Press releases
- Publications
ExeVir Bio Appoints a Chief Scientific Officer
Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company
September 1, 2023
Read More
ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research
Dengue is a mosquito borne viral infection listed by WHO
June 28, 2023
Read More
Bio International Convention – June 5-8, 2023 – Boston, USA
Our CEO and COO are attending this partnering event in
June 3, 2023
Read More
Antibody Engineering & Therapeutics Europe 2023 – June 6-8, 2023 – Amsterdam, The Netherlands
Our Head of Preclinical Development is attending this event in
June 3, 2023
Read More
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
Currently circulating SARS-CoV-2 variants have gained complete or significant resistance
March 27, 2023
Read More